Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
Publication date:
2019
Publisher version:
Citación:
Bone Marrow Transplantation (2019); doi:10.1038/s41409-019-0525-1
ISSN:
Patrocinado por:
This study was supported in part by the Spanish grant of Instituto de Salud Carlos III (PI16/01485) and FEDER European Union.
Collections
- Artículos [37321]
Files in this item
Métricas
Compartir
